MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 13.02.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
2001 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ CAPITALSPB |
Anteile |
189 M |
Marktkapitalisierung |
$ 19.8 B |
EBITDA (LTM) |
$ -40 M |
P/E (LTM) |
- |
P/S (LTM) |
6.43 |
EPS (LTM) |
-0.86 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Agilent Technologies
A
|
$ 116.36 | 0.7 % | $ 35.4 B | NYSE,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Illumina
ILMN
|
$ 128.32 | 0.34 % | $ 20.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 1.68 | 0.6 % | $ 2.23 M | Nasdaq Capital Market | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 84.5 | 0.2 % | $ 5.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 25.0 | 2.19 % | $ 694 M | Nasdaq Global Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 415.6 | 1.23 % | $ 12 B | Nasdaq Global Select Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Koninklijke Philips N.V.
PHG
|
$ 27.65 | 0.66 % | $ 20 B | NYSE |  Niderland |
 |
CareDx, Inc
CDNA
|
$ 21.56 | 1.53 % | $ 1.15 B | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Senseonics Holdings
SENS
|
$ 7.03 | -0.28 % | $ 293 M | NYSE American | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
$ 52.75 | 0.05 % | $ 2.68 B | Nasdaq Capital Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Fulgent Genetics
FLGT
|
$ 16.26 | -0.31 % | $ 492 M | Nasdaq Global Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Thermo Fisher Scientific
TMO
|
$ 470.43 | 0.18 % | $ 177 B | NYSE,SPB | USA |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Trinity Biotech plc
TRIB
|
$ 0.65 | -0.62 % | $ 61.9 M | Nasdaq Global Select Market |  Irlanda |
 |
Charles River Laboratories International
CRL
|
$ 173.04 | 1.91 % | $ 8.58 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 60.29 | -1.07 % | $ 3.61 B | Nasdaq Global Select Market,SPB | USA |
 |
Guardant Health
GH
|
$ 89.18 | 0.3 % | $ 11.2 B | Nasdaq Global Select Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.98 | - | $ 8.76 M | Nasdaq Global Select Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Neogen Corporation
NEOG
|
$ 9.59 | 0.52 % | $ 2.08 B | Nasdaq Global Select Market,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.17 | 1.4 % | $ 4.98 M | Nasdaq Capital Market | USA |
 |
National Research Corporation
NRC
|
$ 17.46 | 1.33 % | $ 391 M | Nasdaq Global Select Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 101.74 | -0.43 % | $ 8.39 B | Nasdaq Global Select Market,SPB | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
$ 264.08 | 0.11 % | $ 22 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 126.32 | 4.37 % | $ 5.91 B | Nasdaq Global Select Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
NeoGenomics
NEO
|
$ 8.35 | 0.72 % | $ 1.07 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.86 | 1.57 % | $ 450 M | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 205.24 | 0.73 % | $ 20.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 196.28 | 0.04 % | $ 21.8 B | NYSE,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |